Alpha 2.0
Login Register
» Articles » PMID: 3010840

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine Compared with That of Acyclovir Against Human, Monkey, and Rodent Cytomegaloviruses

Overview
Journal Antimicrob Agents Chemother
Publisher American Society for Microbiology
Specialty Pharmacology
Date 1985 Aug 1
PMID 3010840
Citations 31
Authors
V R Freitas
D F Smee
M Chernow
R Boehme
T R Matthews
Affiliations
Soon will be listed here.
Abstract

The activities of the purine acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) against two human and five animal strains of cytomegalovirus were compared with those of acyclovir. DHPG was significantly more active than acyclovir against all but one (mouse cytomegalovirus) of the strains tested, with 50% effective doses ranging from 5 to 13 microM, as determined by plaque reduction assays in human embryonic lung (MRC-5) and human embryonic tonsil cells. Both DHPG and acyclovir inhibited virus replication at concentrations considerably lower than those necessary to inhibit cell proliferation. In mode-of-action studies, the triphosphates of DHPG and acyclovir inhibited human cytomegalovirus DNA polymerase. DHPG phosphorylation to the active triphosphate was enhanced in infected cells; however, this enzymatic activity was unrelated to thymidine kinase. In animal studies, DHPG was slightly more effective than acyclovir in reducing mouse cytomegalovirus-induced mortality.

Citing Articles

Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.

Marschall M, Schutz M, Wild M, Socher E, Wangen C, Dhotre K Cells. 2024; 13(16.

PMID: 39195228 PMC: 11352327. DOI: 10.3390/cells13161338.

HCMV Antivirals and Strategies to Target the Latent Reservoir.

Perera M, Wills M, Sinclair J Viruses. 2021; 13(5).

PMID: 34062863 PMC: 8147263. DOI: 10.3390/v13050817.

Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.

Chen H, Lawler J, Filman D, Hogle J, Coen D mBio. 2021; 12(1).

PMID: 33563814 PMC: 7885103. DOI: 10.1128/mBio.03492-20.

A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.

Selby P, Shakib S, Peake S, Warner M, Yeung D, Hahn U Clin Pharmacokinet. 2021; 60(6):727-739.

PMID: 33515202 DOI: 10.1007/s40262-020-00982-z.

Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89.

Gentry B, Phan Q, Hall E, Breitenbach J, Borysko K, Kamil J Antimicrob Agents Chemother. 2014; 59(1):226-32.

PMID: 25348532 PMC: 4291354. DOI: 10.1128/AAC.03686-14.

References
1.
Kelsey D, Kern E, Overall Jr J, Glasgow L . Effect of cytosine arabinoside and 5-iodo-2'-deoxyuridine on a cytomegalovirus infection in newborn mice. Antimicrob Agents Chemother. 1976; 9(3):458-64. PMC: 429552. DOI: 10.1128/AAC.9.3.458. View
2.
Biron K, STANAT S, Sorrell J, Fyfe J, Keller P, Lambe C . Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc Natl Acad Sci U S A. 1985; 82(8):2473-7. PMC: 397581. DOI: 10.1073/pnas.82.8.2473. View
3.
ESTES J, Huang E . Stimulation of cellular thymidine kinases by human cytomegalovirus. J Virol. 1977; 24(1):13-21. PMC: 515905. DOI: 10.1128/JVI.24.1.13-21.1977. View
4.
Schaeffer H, Beauchamp L, de Miranda P, ELION G, Bauer D, Collins P . 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978; 272(5654):583-5. DOI: 10.1038/272583a0. View
5.
Hsiung G, Choi Y, Bia F . Cytomegalovirus infection in guinea pigs. I. Viremia during acute primary and chronic persistent infection. J Infect Dis. 1978; 138(2):191-6. DOI: 10.1093/infdis/138.2.191. View